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Efflux pumps are membrane transporters that actively extrude various substrates, leading
to multidrug resistance (MDR). In this study, we have designed a new test that allows
investigating the assembly of the MexA-MexB-OprM efflux pump from the Gram negative
bacteria Pseudomonas aeruginosa. The method relies on the streptavidin-mediated
pull-down of OprM proteoliposomes upon interaction with MexAB proteoliposomes
containing a biotin function carried by lipids. We give clear evidence for the importance of
MexA in promoting and stabilizing the assembly of theMexAB-OprM complex. In addition,
we have investigated the effect of the role of the lipid anchor of MexA as well as the role of
the proton motive force on the assembly and disassembly of the efflux pump. The assay
presented here allows for an accurate investigation of the assembly with only tens of
microgram of protein and could be adapted to 96 wells plates. Hence, this work provides
a basis for the medium-high screening of efflux pump inhibitors (EPIs).
Keywords: multidrug resistance, efflux pump, membrane protein, proteoliposome, macro-molecular assembly
Introduction
In Gram-negative bacteria, efflux transporters play a major role in the emergence of antibiotic
resistance thanks to their ability to export drugs out of the cell (Nikaido, 2009). They are organized as
tripartite systemswhere the RNDpump (member of the Resistance,Nodulation, cell Division family)
is located in the inner membrane and works in conjunction with a periplasmic protein belonging
to the MFP family (Membrane Fusion Protein family), and an outer membrane channel (from the
OMF, outer membrane factor family). The cytoplasmic inner membrane protein acts as an energy-
dependent pump with broad substrate specificity. The outer membrane protein acts as a porin
whereas the third one is thought to stabilize the whole complex. The understanding of these pumps
has been largely improved thanks to the publication of high-resolution structures of the various com-
ponents (Hinchliffe et al., 2013) but the overall mechanism of assembly as well as the stoichiometry
of assembly is still a matter of controversy. Two main models have been suggested for a complete
Abbreviations: ßOG, beta-octyl glucopyranoside; DDM, dodecyl maltoside; EthB, Ethidium bromide. DOPC,
1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; RND, Resistance,
Nodulation, cell Division family; OMF, outer membrane factor family; MFP,Membrane Fusion family; ITC, isothermal
titration calorimetry; SPR, surface plasmon resonance.
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description of the pump assembly. In the first one there is a
direct docking of the RND protein on the OMF. In this model,
three or six copies of the MFP stabilize the complex. This direct
docking model has been comforted by the characterization of
a direct interaction between AcrB and TolC by cross-linking
(Tamura et al., 2005; Symmons et al., 2009; Weeks et al., 2010)
and by in vitro surface plasmon resonance (SPR; Tikhonova et al.,
2011). A second model where the MFP, assembled in a funnel-
like conformation with a stoichiometry of 6- 12 copies acts as a
bridge between the RND and the OMF, has been comforted by
recent electron microscopy studies (Trépout et al., 2010; Du et al.,
2014; Kim et al., 2015). This controversy builds up on a series of
biochemical and biophysical characterizations. Indeed it is known
for long that a genuine tripartite complex can be purified, without
prior cross-linking, simply by using a hexahistidine tag on each of
the proteins (Tikhonova and Zgurskaya, 2004). The assembly can
be also studied in vivo, by screening mutants and assessing their
ability to restore resistance against antibiotics (see, e.g., Nehme
and Poole, 2007) or by taking advantage of the sensitivity of bac-
terial cells to vancomycin, a very large antibiotic that cannot pen-
etrate the cell by slow passive diffusion (Bavro et al., 2008): Gram
negative bacteria are not sensitive to vancomycin but become so
if the OMF were to open upon assembly, thereby allowing the
antibiotic to diffuse inside the cell. This strategy has been used
to study the efflux pump MtrC-MtrD-MtrE (respectively MFP-
RND-OMF) from Neisseria gonorrhoea (Janganan et al., 2013).
The assembly has also been studied in vitro by isothermal titration
calorimetry (ITC), a technique that allowed for the evaluation
of the affinity between components and the establishment of a
four-stagemodel where four sequential, non-cooperative, binding
sites are suggested (Touzé et al., 2004). Following similar lines,
the assembly of the whole complex has been studied by (SPR;
Tikhonova et al., 2011). Upon injection of the protein partners
(premixed or in a sequenced manner) on a biochip onto which
AcrB was adsorbed, they could monitor assembly in real time.
The tripartite complex successfully formedonlywhen the partners
were mixed in following a specific sequence of events.
In spite of the valuable and continued efforts for understand-
ing how a tripartite efflux pump assembles, the development
of original solutions compatible with medium-high screening of
inhibitors is lacking. Antibiotic resistance is an increasing threat
complicated by the scarcity of new anti-infective drug families
under development. Hence, finding new ways to inhibit efflux
pumps is a very promising and important endeavor because it
was shown that such inhibitors restore the activity of antibi-
otics (Lomovskaya et al., 2006; Pages and Amaral, 2009). Lately,
we have described a new protocol where transport through the
whole pump could be monitored by use of proteoliposomes and
respective fluorescent probes liable to report the activity of each
partner of the pump (Verchère et al., 2015). As a complementary
approach we present here a new strategy that allows investigating
the formation of efflux pumps.
Materials and Methods
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl;
DOPE, cap biotin) were purchased from Avanti Polar Lipids
(reference: 850375C and 870273C, respectively). SM2 Bio-beads
were obtained from Bio-Rad (reference 152-3920). n-dodecyl-b-
D-maltopyranoside (DDM) and n-octyl-ß-D-glucopyranoside
(ß-OG) was purchased from Anatrace (reference D310LA and
O311, respectively).
Production, Purification of MexB
MexB was purified following the protocol described in
(Mokhonov et al., 2005), with minor modifications. Heterologous
expression was performed in a C43 DAcrB strain. A pre-culture
was grown overnight at 37°C under agitation at 200 rpm and
inoculated at OD600nm = 0.05 in 2xTY medium containing
100 mg/mL of ampicillin. Cell were grown to OD600nm = 0.6
at 30°C at 200 rpm and then cooled down at 4°C for 30 min.
Isopropyl b-D-1- thiogalactopyranoside (IPTG) was added
(1 mg/mL final) and growth was continued overnight at 20°C.
Cells were then lysed thanks to a cell-disrupter (Cell-D from
Constant LTD) at 4°C after two passages at 2.4 kbar. Membranes
were collected upon centrifugation at 100,000 g during 1 h at
4°C. Solubilization was performed overnight at 4°C in 10 mM
Bis-Tris pH 7.4; glycerol 20%, 10 mM imidazole and 500 mM
NaCl at a 2:1 detergent-to-protein ratio (protein concentration
was determined using the Bicinchoninic acid test from Sigma).
Purification was performed by affinity chromatography followed
by a gel filtration (superose 6 HR, GE).
Production, Purification of MexA
MexA was purified following the protocol described in (Akama
et al., 2004) with minor modifications. Heterologous expression
was performed in a C43 DAcrB strain. A pre-culture was grown
overnight at 37°C under agitation at 200 rpm and inoculated
at OD600nm = 0.05 in 2xTY medium containing 25 mg/mL of
chloramphenicol. Cell were grown to OD600nm = 0.6 at 30°C at
200 rpm and then cooled down at 4°C for 30 min. Arabinose
was added (0.02% final, w/v) and growth was continued during
2.5 h at 30°C. Cells were then lysed thanks to a cell-disrupter
(Cell-D from Constant LTD) at 4°C after two passages at 2.4
kbar. Membranes were collected upon centrifugation at 100,000 g
during 1 h at 4°C. Solubilization was performed overnight at room
temperature in 20 mM Tris-HCl pH 8, glycerol 10%, 15 mM imi-
dazole at a 40:1 detergent-to-protein ratio (protein concentration
was determined using the Bicinchoninic acid test from Sigma).
Purification was performed by affinity chromatography followed
by a gel filtration (superose 6 HR, GE). A truncated form ofMexA
“cysteine-less,” named MexAnp, without its first 24 residues, has
been generated in the laboratory in order to produce and purify a
non-palmitoylated, soluble version of the protein.
Production, Purification of OprM
OprM is purified following the protocol described in (Phan
et al., 2010) with minor modifications. In brief, the procedure
was exactly that described above for MexA except that an addi-
tional solubilization step is added on the membrane pellet: N-
octylpolyoxyethylene (C8POE) is added (2% final, w/v) and the
mixture was incubated 30 min at 37°C. C8POE is a detergent
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that has been shown to specifically solubilize bacterial inner
membranes.
Production, Purification of the RNA Scaffold
Purification of the RNA scaffold, dubbed ref-f, was performed
as described in Ponchon et al. (2013). Heterologous expression
was achieved in XL1 cells. A pre-culture was grown 10 h at 37°C
under shaking at 200 rpm and inoculated at OD600nm = 0.05 in
LBmedium containing 100mg/mL of ampicillin. Cell were grown
overnight to OD600nm = 3 at 37°C at 200 rpm. The expression of
ref-f is induced by the addition of 1 mM of IPTG. After 3 h, cells
were centrifuged at 7000 g, during 20 min at room temperature.
Pellets were re-suspended in 1L of buffer containing 20 mM Tris,
200 mM NaCl and centrifuged at 7000 g, during 20 min, again
at room temperature. Pellets were re-suspended in 40 mM of
MgSO4, 50mMNa3Citrate pH 5.6. RNAwas extracted upon incu-
bation with 40 mL of phenol during 2 h under gentle stirring at
room temperature. Themixture was centrifuged 15min at 3200 g.
The supernatant was incubated with two volumes of ethanol and
1/20 of NaCl 5 M, a precipitate was formed and the mixture was
centrifuged 5 min at 3200 g. The pellet was dried under the fume
hood for 5 min and 10 mL of distilled water was added. The RNA
was then purified by anion exchange chromatography.
Preparation of Unilamellar Vesicles
A mix of lipids consisting of DOPC and DOPE with cap biotin at
a 20:1 w/w ratio were dissolved in 25 mM HEPES pH7, 100 mM
K2SO4 and 2 mM MgSO4, to a final concentration of 1 mg/mL.
The suspension was then heated for 10 min at 37°C. This solution
was then sonicated for 10 min with 300 pulse/300 pause cycles.
Liposomeswere subsequently passed through 200 nmmembranes
and then 100 nm membranes thanks to an extruder from Avanti
(20 pass for each type of membrane). The homogeneity of the
suspension was controlled by Dynamic Light scattering (DLS,
Nanosizer Malvern).
Reconstitution of the Proteins
Liposomes were first solubilized at a 1:1 detergent to lipid ratio
(w/w). Solubilization was performed using ß-OG for 1 h at 20°C
under gentle agitation. Proteins were added to the solubilized
liposome suspension at the following lipid-to-protein ratio (w/w):
MexB 1:20;MexA, 1:30; OprM, 1:20. OprMproteoliposomes were
prepared in the presence of ref-f at 3 mg/ml: MexAB proteolipo-
somes were prepared the presence of 3 mM pyranine. Detergent
removal was achieved upon 3 consecutive additions of Bio-beads
(previously washed with methanol, ethanol and water) at a Bio-
bead: detergent ratio of 20 (w/w) for at 1 h at 20°C, followed
by an eventual addition, overnight, at the same ratio. MexAB
proteoliposomes were purified from untrapped pyranine using a
PD-10 desalting column (GEHealthcare). OprMproteoliposomes
were purified from untrapped RNA using source Q column (GE
Healthcare).
The efficiency of the reconstitution is controlled by running a
discontinuous sucrose gradient formed of five layers (60, 20, 10,
5 and 2.5% sucrose). After ultracentrifugation of liposomes on
this sucrose gradient overnight at 100,000 g, non-incorporated
proteins are found at the bottom of the tube, while proteoli-
posomes are trapped at a sucrose interface that corresponds to
their intrinsic density. Empty liposomes are recovered higher in
the gradient. Different gradient fractions are collected gently and
analyzed on SDS-PAGE using Coomassie staining.
Ethidium Bromide Transport
Ethidium bromide (EthB) transport was measured as previously
described (Verchère et al., 2015). Fluorescence measurements
were conducted at 25°C using a SAFAS-Xenius spectrofluorime-
ter. Themeasurementswere performed using the dual-wavelength
mode, with excitation and emissionwavelengths set at 300 nm and
600 nm, respectively, for the recording of EthB fluorescence and
at 455 nm and 509 nm for the recording of pyranine fluorescence.
Bandwidths were set at 10 nm. 100mL of OprM proteoliposomes
and 100 mL of MexAB proteoliposomes were mixed and diluted
with 800mL of the liposome reconstitution buffer (25 mM Hepes
pH7, 100 mM K2SO4, 2 mMMgSO4). The system was then incu-
bated until a steady baseline was obtained. EthB was then added
at 5mM and a pH jump was performed after 20 min incubation.
Pull Down Assay
100mL of the respective liposomesweremixed and the suspension
was then complemented with 800mL of the liposome reconstitu-
tion buffer (25 mM Hepes pH7, 100 mM K2SO4, 2 mMMgSO4),
when the assembly is performed under non-energized conditions
(see x Investigation of the assembly) or with 800mL of a buffer
containing 20 mMMes Tris pH6, 100 mM K2SO4, 2 mMMgSO4
when the assembly is performed under pH gradient conditions
(see x Liposome pull down as a complementary approach to a
transport assay, below). Both buffers have been tuned in order to
have the same osmolarity, as measured by a cryoscopic Osmome-
ter (Fisher Scientific, reference: 11900557). Then, the liposomes
are incubated for 20 min at room temperature. Finally, 5 mL of
MagStrep resin (MagStrep “type2HC” high capacity beads, IBA)
at 5% (50 mg/mL) was added and the suspension was then placed
on a magnetic separator (IBA, ref. 2-1602-000) in order to mag-
netize down the MexAB-biotin enriched-proteoliposomes and
their potential interacting partner. Within a couple of minutes,
the target proteins are specifically pelleted. The corresponding
pellets were washed twice with 1 ml of 100 mM Tris HCl pH8,
150 mM NaCl before being resuspended directly in a 5X acry-
lamide gel loading buffer. The proteins were revealed on 10% gels
by Laemmli-type SDS-PAGE (Laemmli, 1970) and stained with
Coomassie blue.
Results
Investigation of the Assembly
Streptavidin- or streptactin-coated beads are classically used to
purify biotinylated proteins, or proteins containing a strep tag,
by affinity chromatography procedures. Here, we take advantage
of streptavidin-coated magnetic beads to specifically sediment
MexAB proteoliposomes containing biotinylated lipids. As can be
seen Figure 1, when MexAB proteoliposomes are preincubated
with OprM proteoliposomes, OprM is eventually found in the
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FIGURE 1 | MagStrep-mediated pulldown of proteoliposomes allows for
an identification of the formation tripartite complexes. Lane 1 contains
molecular mass markers (PageRuler Prestained Protein Ladder from Thermo
Scientific, #26616). Detergent-purified MexA, MexB, OprM are loaded (2–5 mg
protein per lane) onto a 10% SDS-PAGE Laemmli gel as reference (lanes 2, 3,
and 4, respectively) and stained with Coomassie Blue. Proteoliposomes
containing MexA and MexB (lane 5), MexA and MexBD407N (lane 6), MexB alone
(lane 7), or MexB in the presence of a soluble version of MexA (lane 8) were
mixed with proteoliposomes containing OprM as described in the Material and
Methods section. Liposomes were sedimented and the pellets were mixed with
5 mL loading buffer before being loaded on the gel. The samples were not boiled
in order to avoid aggregation of the membrane proteins.
pellet after sedimentation by the streptavidin-coated magnetic
beads, thereby providing a clear evidence of the assembly in vitro
(see the presence of MexA, MexB, and OprM, lane 6, by com-
parison with the protein standards lane 2, 3, and 4, respectively).
Note that in addition to the presence of OprM itself, one can
see complexes of very high molecular mass in the upper part of
the gel. These complexes were extracted from the gel, incubated
for 1.5 h in water at room temperature and treated under mild
heating conditions (60°C for 15 min in SDS PAGE loading dye).
This revealed that the highmolecularmass complexes were OprM
aggregates (data no shown). As a control, we have performed the
same experiment in the absence of MexA. MexA is a periplasmic
protein that is covalently attached to the membrane via a lipid
anchor. When MexB is reconstituted in the absence of MexA,
OprM is not found in the pellet (lane 7), in accordance with the
well-documented role of MexA on the formation of the pump.
Interestingly, when a soluble version of MexA is added on the
latter system, the formation of the complex is not restored (lane
8). Once again, this result is reminiscent with studies that showed
that the absence of the lipid anchor severely impairs the ability
for the efflux pump to form (Ferrandez et al., 2012). It must be
put forward that the soluble version of MexA does not restore
the ability to form the complex but is nevertheless able to bind to
MexB, as bothMexA andMexB are identified on lane 8. Finally, we
also decided to study if the complex can form if the experiment is
performed in the presence of an inactive version ofMexB,mutated
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B
A
FIGURE 2 | The pull down assay can be adapted in conditions
mimicking the transport. (A) Dual wavelength fluorescence
monitoring of transport. Fluorescence measurements were conducted
with excitation and emission wavelengths set for the recording of EthB
and pyranine fluorescence. OprM proteoliposomes and of MexAB
proteoliposomes were mixed and incubated with EthB (5 mM) and a
pH jump, indicated by an arrow, was performed after 20 min
incubation. The concomitant fluorescence variations of pyranine (see
A, red trace) and EthB (see A, blue trace) is the proof of actual
transport of the substrate from one vesicle to the other.
(B) MagStrep-mediated pulldown of proteoliposomes under
conditions of a pH gradient. The liposomes used in the experiment
shown (A) were enriched with biotinylated lipids in order to investigate
the kinetics of the tripartite complex assembly in the context of
transport. Samples were prepared as described in the Material and
Methods section and were incubated for 20 min before being diluted
with a buffer containing 20 mM Mes Tris pH6, 100 mM K2SO4, 2 mM
MgSO4 in order to generate a pH gradient. Streptavidin-coated
magnetic beads were then added either immediately (t0) or after a
5-min incubation (t = 5 min).
in the proton relay pathway (D407N mutant, Guan and Nakae,
2001; Su et al., 2006; Takatsuka and Nikaido, 2006), and in the
presence of the palmitoylated version of MexA. Lane 5 shows
that the complex does form in this condition showing that the
mutation, located in the transmembrane part of the protein, does
not affect the formation of the pump.
Frontiers in Microbiology | www.frontiersin.org June 2015 | Volume 6 | Article 5415
Enguéné et al. Reconstitution of an efflux pump in proteoliposomes
Liposome Pull Down as a Complementary
Approach to a Transport Assay
We have previously shown that transport through the whole tri-
partite pump can be measured thanks to the use proteoliposomes
loaded with fluorescent probes that report the activity of MexB
and OprM (Verchère et al., 2015). In brief, MexA and MexB
are reconstituted in proteoliposomes containing pyranine, while
OprM is reconstituted in another kind of proteoliposome inwhich
RNA is encapsulated. Besides, EthB, a substrate of the pump that
has DNA-intercalating properties is incubated with the proteins.
Pyranine is a pH-dependent probe which fluorescence decreases
when pH decreases. EthB fluorescence increases significantly
upon intercalation into nucleic acids. Because the pump is ener-
gized by the proton motive force (Thanassi et al., 1997; Li et al.,
1998; Zgurskaya and Nikaido, 1999), transport can be triggered
by generating a change in the pH in the external medium (the pH
jump is indicated by an arrow, Figure 2A). Efflux is monitored by
measuring the simultaneous fluorescence variations of pyranine
(see Figure 2A, red trace) and EthB (see Figure 2A, blue trace):
the concomitant fluorescence variations indicate actual transport
of the substrate from one vesicle to the other (the increase of EthB
fluorescence is ascribed to the intercalation into RNA), mediated
by an active transport through the pump (the decrease of pyranine
fluorescence is the result of proton counter-transport, hence the
acidification of the liposome, by MexB). If the same experiment
is now performed in the presence of proteoliposomes where the
MexABD407N inactive mutant is used, both the pyranine and EthB
fluorescence signals remain steady (see Verchère et al., 2015).
The liposomes used in the experiment shown Figure 2A were
enriched with biotinylated lipids in order to investigate the kinet-
ics of the tripartite complex assembly in the context of transport,
using the pull-down protocol on the very same proteoliposome
preparation. To that purpose the proteoliposomes were incubated
as described in the previous paragraph except that the buffer
used to dilute the liposomes was now more acidic than that in
which the proteoliposomes were prepared. As a consequence, a
pH gradient is generated across the liposome membrane. As can
been seen Figure 2B, the tripartite complex is observed upon
generation of the pH gradient, as OprM is detected together with
MexA andMexB (see “MexAB samples” prepared at t0). However,
after transport has reached steady state (i.e., within a couple of
minutes), the complex has seemingly disappeared. Indeed, OprM
does no longer interact with MexAB (see the “MexAB samples”
prepared at t = 5 min). Interestingly, when the same experiment
is performed in the presence of the D407N mutant, the complex
remains stable (see “MexABD407N samples” prepared at t0 and at
t = 5 min).
Discussion
An Original Technique Allowing to Monitor
Transport and Assembly
The formation of the macromolecular complex formed by MexA,
MexB, and OprM has been studied for long, by use of various
biochemical and biophysical techniques. Theses studies made it
possible to understand key aspects of the mechanism of an efflux
pump but they are rather demanding in term of protein quantity
(ITC) and methodology (in SPR, the target protein must be
attached on the sensor chip and must remain stable throughout
the whole titration experiment). As presented here, our protocol
is much more versatile, it is compatible with a medium-large
screening of potential inhibitors as it does not require large
amounts of protein (typically 10mg of protein is necessary for one
measurement). Finally, this protocol can be scaled up in 96-wells.
In such a case, SDS-PAGE would not be the best identification
option but we have adapted the protocol by using OprM proteoli-
posomes enriched with lipids grafted with a rhodamine function.
In such a context, the purple color of the liposomes remains in
the supernatant when the complex is not formed, the purple color
being lost in the pellet if the complex forms (data not shown).
Hence, the assembly could be simply monitored by colorimetry.
Our methodology finds its limit in being only qualitative. Indeed,
the variability of the efficiency of reconstitution, and the repro-
ducibility of the procedure (washing of the pellets, resuspension
in the loading buffer) precludes from any quantitative conclusion.
Hence, we can not claim any information on the stoichiometry.
Role of MexA
The results presented Figure 1 show that MexA is absolutely
necessary for the assembly, a result in accordance with previous
results. Tikhonova et al. (2011) showed that if anHis-tag is located
on AcrA or AcrB, a tripartite complex can be purified in mea-
surable quantities from bacterial native membranes. However, if
the His-tag is placed on TolC, only traces of the complex are
purified. AcrA is thus indispensable for AcrB to co-fractionate
with OprM (Tikhonova and Zgurskaya, 2004). The interaction
between the different partners has also been investigated using
ITC, which allows evaluating the affinity between two compo-
nents (Touzé et al., 2004).When the interaction betweenAcrB and
TolC is investigated by ITC measurement, no stable interaction is
detected. This was interpreted by the fact that AcrA is required for
the interaction between AcrA and TolC.
Finally, the efflux pump MtrC-MtrD-MtrE (respectively MFP-
RND-OMF) from Neisseria gonorrhoea has also been intensely
investigated in vivo by Janganan et al. (2013). They made use of
vancomycin susceptibility to monitor the assembly of the OMF
with its RND and MFP partners (Janganan et al., 2013). Gram
negative bacteria are not susceptible to vancomycin but become
so if the OMF were to open and let the antibiotic diffuse inside
the cell. Interestingly if the MFP is expressed together with the
OMF, cells become sensitive to vancomycin, meaning that the
MFP is required for the OMF to open. Note that, it was shown
that a truncated version of theMFP, consisting of the alpha helical
hairpin domain only, is not able to open the OMF. Finally the
assembly of the whole complex wasmonitored by SPR (Tikhonova
et al., 2011), showing that AcrA-AcrB and AcrA-TolC complexes
can be detected. If palmitoylated AcrA and TolC are premixed and
then injected on AcrB adsorbed on solid support, the complex
does not form, probably because TolC inhibits the interaction
between AcrB and AcrA.
The reason for the fact that the soluble MexA does not restore
the formation of the complex remains an open question. It could
very well be that this construction is intrinsically unable to make
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the pump assemble but one can also imagine that this inability
to form a complex is purely thermodynamic. Indeed, the lipid
anchor may be present for restricting the diffusion of the protein
to a two-dimensional space, thereby allowing a more probable
interaction with MexB. However, the role of the N-terminal lipid
part of AcrA, was investigated in real time by SPR (Tikhonova
et al., 2011) and it was shown that when the MFP lacks its lipid
anchor, no oligomerization of the MFP is detected. Considering
that AcrA binds AcrB as a dimer, it seems probable that the lipid
anchor has a genuine effect on the assembly.We have to stress that
the observation that the soluble version of MexA is nevertheless
able to bind MexB (see Figure 1, lane 8) is in contradiction with
the fact that Tikhonova et al. showed that the binding of soluble
AcrA to AcrB is very weak at pH7.5 and pH6.
Role of pmf on the Assembly
We show that the mutation within the proton relay pathway does
not impair the assembly, which indicates that the efflux pump
assembly does not require transport activity. Again, this result
is in line with the work of Tikhonova and Zgurskaya regarding
the assembly of the AcrAB-TolC pump from native bacterial
membranes (Tikhonova and Zgurskaya, 2004) where they showed
that if the corresponding non-functional mutant of AcrB (AcrB
Asp408Ala) is expressed, the complex is still co-purified. Besides,
if the proton motive force is disrupted in the cells (using CCCP,
valinomycin and/or nigericin) the complex is also co-purified.
Role of pmf on the Disassembly
In a remarkable series of papers, Bavro et al. (2008) previously
investigated the energy dependence of the pump assembly, by
use of non- functional mutants of MtrD mutated in residues
involved in the proton-transducing pathway (Asp405, Asp406,
and Lys948). If these mutants are expressed with the MFP and
the OMF, cells remain insensitive to vancomycin; indicating that
the efflux pump must dissociate under the proton motive force.
Although very elegant, this conclusion is indirect and is realized
in the context of the bacteria where additional factors could be
suspected. Figure 2 provides direct and non-ambiguous support
for the fact that the proton motive force indeed promotes dis-
assembly of the complex, as evidenced by i) the disappearing of
OprM when the wild type pump has reached its steady state and
ii) by the maintaining of the assembly when the D407N mutant,
defective in proton translocation, is used.
Conclusion
We were able to detect the assembly of an efflux pump after it has
been reconstituted into proteoliposomes. We could discriminate
between conditions that allow, or favor, the formation of the
complex and could also confirm that MexA is mandatory for the
assembly to take place. Hence, this is in accordance with several
studies obtained in recent years on that matter. Our reconstitution
method and the subsequent characterization approach described
in the present work allow us to consider further studies of recon-
stitutions including proteinsmutated at various positions, in order
to shed light on the actual determinants of transport in a simple
system in a bottom-up approach.
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